These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20377893)

  • 1. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
    Philips MA; Kingo K; Karelson M; Rätsep R; Aunin E; Reimann E; Reemann P; Porosaar O; Vikeså J; Nielsen FC; Vasar E; Silm H; Kõks S
    BMC Med Genet; 2010 Apr; 11():56. PubMed ID: 20377893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.
    Dwivedi M; Laddha NC; Begum R
    J Dermatol Sci; 2013 Sep; 71(3):195-202. PubMed ID: 23706493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
    Giri PS; Patel S; Begum R; Dwivedi M
    Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myg1 exonuclease couples the nuclear and mitochondrial translational programs through RNA processing.
    Grover R; Burse SA; Shankrit S; Aggarwal A; Kirty K; Narta K; Srivastav R; Ray AK; Malik G; Vats A; Motiani RK; Thukral L; Roy SS; Bhattacharya S; Sharma R; Natarajan K; Mukerji M; Pandey R; Gokhale RS; Natarajan VT
    Nucleic Acids Res; 2019 Jun; 47(11):5852-5866. PubMed ID: 31081026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of MYG1 gene and protein: subcellular distribution and function.
    Philips MA; Vikeså J; Luuk H; Jønson L; Lilleväli K; Rehfeld JF; Vasar E; Kõks S; Nielsen FC
    Biol Cell; 2009 Jun; 101(6):361-73. PubMed ID: 19014353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.
    Ren Y; Yang S; Xu S; Gao M; Huang W; Gao T; Fang Q; Quan C; Zhang C; Sun L; Liang Y; Han J; Wang Z; Zhang F; Zhou Y; Liu J; Zhang X
    PLoS Genet; 2009 Jun; 5(6):e1000523. PubMed ID: 19543371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.
    Laddha NC; Dwivedi M; Mansuri MS; Singh M; Patel HH; Agarwal N; Shah AM; Begum R
    PLoS One; 2014; 9(9):e107020. PubMed ID: 25221996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in melanocortin system and MYG1 genes are associated with vitiligo.
    Traks T; Keermann M; Karelson M; Rätsep R; Reimann E; Silm H; Vasar E; Kõks S; Kingo K
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):e65-e67. PubMed ID: 30051642
    [No Abstract]   [Full Text] [Related]  

  • 9. MYG1, novel melanocyte related gene, has elevated expression in vitiligo.
    Kingo K; Philips MA; Aunin E; Luuk H; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S
    J Dermatol Sci; 2006 Nov; 44(2):119-22. PubMed ID: 16996721
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.
    Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R
    Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
    Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
    Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor (TNF)-α- 308 G/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis.
    Abd El-Raheem T; Mahmoud RH; Hefzy EM; Masoud M; Ismail R; Aboraia NMM
    PLoS One; 2020; 15(12):e0240221. PubMed ID: 33370782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of elevated homocysteine levels and Methylenetetrahydrofolate reductase (MTHFR) 1298 A > C polymorphism with Vitiligo susceptibility in Gujarat.
    Jadeja SD; Mansuri MS; Singh M; Patel H; Marfatia YS; Begum R
    J Dermatol Sci; 2018 May; 90(2):112-122. PubMed ID: 29395581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients.
    Namian AM; Shahbaz S; Salmanpoor R; Namazi MR; Dehghani F; Kamali-Sarvestani E
    Arch Dermatol Res; 2009 Jan; 301(1):21-5. PubMed ID: 18820938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
    Laddha NC; Dwivedi M; Begum R
    PLoS One; 2012 Dec; 7(12):e52298. PubMed ID: 23284977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of single nucleotide polymorphisms of Nrf2 promoter region with susceptibility to vitiligo].
    Zhou MN; Xu AE; Lu LJ; Li YW; Zhao DK; Guan CP
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):969-72. PubMed ID: 18756969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide synthase promoter polymorphism: a molecular susceptibility marker for vitiligo in Egyptians.
    Zayed AA; Khorshied MM; Hussein MF
    Int J Dermatol; 2015 Jun; 54(6):675-9. PubMed ID: 25556582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations.
    Song P; Li K; Liu L; Wang X; Jian Z; Zhang W; Wang G; Li C; Gao T
    J Cell Mol Med; 2016 Oct; 20(10):1840-50. PubMed ID: 27222475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India.
    Jahan P; Cheruvu R; Tippisetty S; Komaravalli PL; Valluri V; Ishaq M
    J Am Acad Dermatol; 2013 Aug; 69(2):262-6. PubMed ID: 23498308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population.
    Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH
    Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.